The account of the preclinical studies has been structured to highlight the effect of MeCP2 loss in anxiety macrocircuit regions and within cellular subtypes on anxiety-like behaviour and/or physiological response (illustrated within Fig. 2) and subsequently summarises potential underlying molecular mechanisms. The gene discussed is MECP2; the disease is Anxiety.